Scroll to top

CLINUVEL sustains profitability first-half of year

28 February 2018

CLINUVEL PHARMACEUTICALS LTD today announced financial results for the half year ended 31 December 2017, reporting net profit after tax of A$1.41m, and total revenues of A$7.19m:

  • total revenues: A$7.19 million
  • 3% increase in total revenues PRP
  • commercial sales revenues: A$5.33 million
  • cash increase from 30 June 2017: A$4.19 million
  • net profit after tax: A$1.41 million (44% decrease PRP)
  • growth in number of expert treatment centres prescribing SCENESSE®

Download PDF for more 

We use cookies to give you the best experience.